Heart disease, gastrointestinal cancer, liver and kidney placeholder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients only with general anesthesia after elective cardiac and non-cardiac surgery; 2) after IV PCA analgesia; 3) Both men and women, aged 16-75 years old; 4) cardiac function I-III class, ASA I-III level; 5) patients agreed to participate in the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of angina or congestive heart failure, myocardial infarction, coronary revascularization, coronary artery bypass, stroke or transient ischemic attack, uncontrolled hypertension or diabetes, liver disease, kidney disease, bleeding disordersother disorders; 2) composite anesthetized patients; 3) patients without postoperative intravenous PCA analgesia; 4) patients unable to cooperate, or can not understand and perform cognitive scores patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Score;Postoperative morphine requirements;Cognitive Scale score;Postoperative nausea and vomiting;Protein S100; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of adverse cardiovascular events;Pulmonary complication; | — |
Countries
China